Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 21865664)

1.

Mouse models for Down syndrome-associated developmental cognitive disabilities.

Liu C, Belichenko PV, Zhang L, Fu D, Kleschevnikov AM, Baldini A, Antonarakis SE, Mobley WC, Yu YE.

Dev Neurosci. 2011;33(5):404-13. doi: 10.1159/000329422. Epub 2011 Aug 25. Review.

2.

Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Zhang L, Meng K, Jiang X, Liu C, Pao A, Belichenko PV, Kleschevnikov AM, Josselyn S, Liang P, Ye P, Mobley WC, Yu YE.

Hum Mol Genet. 2014 Feb 1;23(3):578-89. doi: 10.1093/hmg/ddt446. Epub 2013 Sep 16.

3.

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N, Carattini-Rivera S, Bechard AR, Spring S, Henkelman RM, Stoica G, Matsui S, Nowak NJ, Roder JC, Chen C, Bradley A, Yu YE.

Hum Mol Genet. 2010 Jul 15;19(14):2780-91. doi: 10.1093/hmg/ddq179. Epub 2010 May 4.

4.

Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).

Roubertoux PL, Carlier M.

Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):400-16. doi: 10.1002/ajmg.c.30280. Review.

PMID:
20981769
5.

Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Rueda N, Flórez J, Martínez-Cué C.

Neural Plast. 2012;2012:584071. doi: 10.1155/2012/584071. Epub 2012 May 22. Review.

6.

Mouse models of cognitive disorders in trisomy 21: a review.

Sérégaza Z, Roubertoux PL, Jamon M, Soumireu-Mourat B.

Behav Genet. 2006 May;36(3):387-404. Epub 2006 Mar 8. Review.

PMID:
16523244
7.

Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.

Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R, Fan N, Zhou Z, Jia Z, Chen C, Roder JC, Liu B, Baldini A, Mobley WC, Yu YE.

Brain Res. 2010 Dec 17;1366:162-71. doi: 10.1016/j.brainres.2010.09.107. Epub 2010 Oct 26.

8.

Pathways to cognitive deficits in Down syndrome.

Sturgeon X, Le T, Ahmed MM, Gardiner KJ.

Prog Brain Res. 2012;197:73-100. doi: 10.1016/B978-0-444-54299-1.00005-4. Review.

PMID:
22541289
9.

From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome.

Cramer N, Galdzicki Z.

Neural Plast. 2012;2012:101542. doi: 10.1155/2012/101542. Epub 2012 Jul 12. Review.

10.

Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.

Contestabile A, Benfenati F, Gasparini L.

Prog Neurobiol. 2010 May;91(1):1-22. doi: 10.1016/j.pneurobio.2010.01.003. Epub 2010 Jan 25. Review.

PMID:
20097253
11.

Down syndrome: genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits.

Busciglio J, Capone G, O'Bryan J, Gardiner KJ.

Cytogenet Genome Res. 2013;141(4):260-71. doi: 10.1159/000354306. Epub 2013 Aug 30. Erratum in: Cytogenet Genome Res. 2014;142(2):94. O'Byran, J P [corrected to O'Bryan, J].

PMID:
24008277
12.

Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.

Edgin JO, Mason GM, Spanò G, Fernández A, Nadel L.

Prog Brain Res. 2012;197:123-51. doi: 10.1016/B978-0-444-54299-1.00007-8. Review.

PMID:
22541291
13.

The in vivo Down syndrome genomic library in mouse.

Herault Y, Duchon A, Velot E, Maréchal D, Brault V.

Prog Brain Res. 2012;197:169-97. doi: 10.1016/B978-0-444-54299-1.00009-1.

PMID:
22541293
14.

Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome.

Ruparelia A, Pearn ML, Mobley WC.

Curr Opin Neurobiol. 2012 Oct;22(5):880-6. doi: 10.1016/j.conb.2012.05.002. Epub 2012 May 30.

15.

Down syndrome--recent progress and future prospects.

Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM.

Hum Mol Genet. 2009 Apr 15;18(R1):R75-83. doi: 10.1093/hmg/ddp010. Review.

16.

Discoveries in Down syndrome: moving basic science to clinical care.

Kleschevnikov AM, Belichenko PV, Salehi A, Wu C.

Prog Brain Res. 2012;197:199-221. doi: 10.1016/B978-0-444-54299-1.00010-8. Review.

PMID:
22541294
17.

Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice.

Yu T, Clapcote SJ, Li Z, Liu C, Pao A, Bechard AR, Carattini-Rivera S, Matsui S, Roder JC, Baldini A, Mobley WC, Bradley A, Yu YE.

Mamm Genome. 2010 Jun;21(5-6):258-67. doi: 10.1007/s00335-010-9262-x. Epub 2010 May 29.

18.

Is it possible to improve neurodevelopmental abnormalities in Down syndrome?

Bartesaghi R, Guidi S, Ciani E.

Rev Neurosci. 2011;22(4):419-55. doi: 10.1515/RNS.2011.037. Review.

PMID:
21819263
19.

Genetic analysis of Down syndrome-associated heart defects in mice.

Liu C, Morishima M, Yu T, Matsui S, Zhang L, Fu D, Pao A, Costa AC, Gardiner KJ, Cowell JK, Nowak NJ, Parmacek MS, Liang P, Baldini A, Yu YE.

Hum Genet. 2011 Nov;130(5):623-32. doi: 10.1007/s00439-011-0980-2. Epub 2011 Mar 26. Erratum in: Hum Genet. 2011 Nov;130(5):633. Nowak, Normal J [corrected to Nowak, Norma J].

20.

Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.

Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC.

J Comp Neurol. 2007 Oct 1;504(4):329-45.

PMID:
17663443
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk